Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

ACC.17: Cerebral embolic protection devices may not improve freedom from stroke, infarction

A randomized study found that using two FDA-approved cerebral embolic protection devices in patients undergoing surgical aortic valve replacement (SAVR) was not associated with an improvement in freedom from clinical or radiographic infarction or clinical stroke.

Thumbnail

ACC.17: Revascularization strategies guided by FFR, iFR have similar adverse cardiac event rates

At 12 months, patients with stable angina or acute coronary syndrome had similar rates of major adverse cardiac events whether they underwent revascularization guided by instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR), according to a randomized, registry-based trial.

ACC.17: Detroit cardiologists increase cardiogenic shock survival rate to 84% using Abiomed heart pump

A coalition of medical centers in southeast Michigan have found a way to increase the survival rate of cardiogenic shock patients to 84 percent by using a heart pump manufactured by Danvers, Massachusetts-based Abiomed. 

ACC.17: Patients with CTOs have similar outcomes with PCIs, optimal medical treatment

Patients with chronic total occlusions (CTOs) had similar results whether they underwent PCIs or received optimal medical treatment, according to a prospective, open-label, randomized trial.

Late-Breaking Data on Abbott's MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease

80.0% OF THOSE TREATED FREE FROM REPEAT HEART FAILURE RE-HOSPITALIZATION

Thumbnail

Study finds 40% of intracerebral hemorrhage survivors have depression within 5 years

Even if patients survive an intracerebral hemorrhage (ICH), they may be at an increased risk of future mental issues.

Thumbnail

FDA warns of increased major adverse cardiac events with the Absorb dissolving stent

After reviewing data from a clinical trial, the FDA issued a letter to healthcare providers informing them that patients who received the Absorb bioresorbable vascular scaffold had an increased rate of major adverse cardiac events compared with patients treated with the Xience drug-eluting stent.

ACC.17: SURTAVI trial finds TAVR, SAVR have similar all-cause mortality rates at 24 months

After two years, intermediate-risk patients with severe symptomatic aortic stenosis had similar rates of all-cause mortality or disabling stroke whether they underwent transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR), according to a randomized trial.

Displaying 5897 - 5904 of 10761

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.